✦ LIBER ✦

Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli

✍ Scribed by Xiaopu Yin; Dongzhi Wei; Lina Yi; Xinyi Tao; Yushu Ma

Book ID: 116827993
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 382 KB
Volume: 41
Category: Article
ISSN: 1046-5928
DOI: 10.1016/j.pep.2004.10.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protection of the isolated rat heart by

Protection of the isolated rat heart by exendin-4, a GLP-1 receptor agonist

✍ David P. Sonne; Thomas Engstrøm; Marek Treiman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Purification and bioactivity of exendin-

Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed inPichia pastoris

✍ Jin Zhou; Ju Chu; Yong-Hong Wang; Hui Wang; Ying-Ping Zhuang; Si-Liang Zhang 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 327 KB

59 CYTOPROTECTIVE EFFECTS OF EXENDIN-4,

59 CYTOPROTECTIVE EFFECTS OF EXENDIN-4, A GLP-1 RECEPTOR AGONIST, ON THE BILIARY EPITHELIUM

✍ M. Marzioni; G. Alpini; S. Saccomanno; G. Fava; C. Candelaresi; C. Rychlicki; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Exendin-4, a GLP-1 receptor agonist, dir

Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression

✍ Le Thi Kim Chung; Toshio Hosaka; Masaki Yoshida; Nagakatsu Harada; Hiroshi Sakau 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Cloning and Functional Expression of the

Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9-39) an Antagonist of the Receptor

✍ Thorens, B.; Porret, A.; Buhler, L.; Deng, S.-P.; Morel, P.; Widmann, C. 📂 Article 📅 1993 🏛 American Diabetes Association 🌐 English ⚖ 893 KB

Exendin-4, a glucagon-like protein-1 (GL

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

✍ Xiaokun Ding; Neeraj K. Saxena; Songbai Lin; Narita Gupta; Frank A. Anania 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning problem in hepatology, and is associated with insulin resistance. Exendin-4 is a peptide agonist of the glucagon-like peptide (GLP) receptor that promotes insulin secretion. The aim of this study was to determine whether administration